rss feeds Last update FDA warns of compounded drug recall by Texas firm, 2 hours ago

Medications news

Supermaterial gives rejected drugs a new chance

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new ...

Jul 22, 2014
popularity 4.5 / 5 (2) | comments 0

NIH system to monitor emerging drug trends

An innovative National Drug Early Warning System (NDEWS) is being developed to monitor emerging trends that will help health experts respond quickly to potential outbreaks of illicit drugs such as heroin and to identify increased ...

Jul 17, 2014
popularity not rated yet | comments 0

Ruconest approved for rare genetic disease

(HealthDay)—Ruconest has been approved by the U.S. Food and Drug Administration to treat hereditary angioedema, a genetic disease that leads to sudden and potentially fatal swelling of the hands, feet, limbs, face, intestinal ...

Jul 17, 2014
popularity not rated yet | comments 0

Changes in generic pill color and shape disrupt use

Generic versions of the same prescription drug are clinically interchangeable but often look different depending on the manufacturer. The FDA does not require consistent pill appearance among interchangeable generic drugs, ...

Jul 14, 2014
popularity 5 / 5 (2) | comments 0

More News Stories

Animal vaccines should guide malaria research

Research into vaccines for malaria in humans should be guided by the success shown in producing effective vaccines for malaria-like diseases in animals, according to a University of Adelaide study.

Express Scripts cuts payments for customized drugs

The nation's largest pharmacy benefit manager, Express Scripts, is dramatically scaling back its coverage of compounded medications, saying most of the custom-mixed medicines are ineffective or overpriced.

Roche buying Seragon in US for up to $1.7 billion

Roche Holding AG says its U.S.-based biotech company Genentech has agreed to acquire American biotechnology firm Seragon Pharmaceuticals, Inc. for up to $1.725 billion in cash and contingency payments.

Novartis Japan unit charged over research manipulation

Japanese prosecutors Tuesday laid charges against the local unit of Swiss pharmaceutical giant Novartis in a widening scandal over claims that falsified data were used to exaggerate the benefits of a popular blood-pressure ...

Common herbal supplement can cause dangerous interactions

St. John's wort, the leading complementary and alternative treatment for depression in the United States, can be dangerous when taken with many commonly prescribed drugs, according to a study by researchers at Wake Forest ...

Other Spotlight Stories

Find more Medications news articles via sort by date page